VYLUMA AND LABORATOIRES THÉA ENTER INTO LICENSING AGREEMENT FOR THE REGISTRATION AND COMMERCIALIZATION OF NVK002 IN CANADA, MEXICO, AND SELECT SOUTH AMERICAN COUNTRIES
Bridgewater, NJ, USA, June 14, 2022 – Vyluma, Inc. (“Vyluma”), a biopharmaceutical company developing multiple assets in the ophthalmic space for the treatment of refractive errors, and Laboratoires Théa (“Théa”) announced that they have recently entered into an...
This link leads to the machine readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine-readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.
https://www.cigna.com/legal/compliance/machine-readable-files